In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor.
Ariey-Bonnet J, Carrasco K, Le Grand M, Hoffer L, Betzi S, Feracci M, Tsvetkov P, Devred F, Collette Y, Morelli X, Ballester P, Pasquier E
Pedro Ballester
Responsable d'équipe Biographie Profil Publons :
https://publons.com/researcher/975063
https://publons.com/researcher/975063
Publications
Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles.
Ogunleye AZ, Piyawajanusorn C, Gonçalves A, Ghislat G, Ballester PJ
Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles.
Naulaerts S, Menden MP, Ballester PJ